Company intelligence / Profile preview

Gramener

New York City / Princeton area ("2 Research Way"), New Jersey, United Statesgramener.com ↗

Ownership: Private
Employees: ~399
Development stage: Other

Overview

Gramener provides advanced data science and AI-driven analytics platforms to accelerate decision-making in pharma/life sciences. Their generative AI tools are used to optimize commercial launches, automate regulatory reporting like Clinical Study Reports, improve stakeholder engagement through automated response systems, and enhance compliance. Quantifiable outcomes include up to 60% time savings in routine tasks for pharmaceutical clients. No clinical results as they do not develop drugs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Microsoft Solution PartnerAWS Software Path Partner

Beyond the preview

Go deeper on Gramener.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gramener.

Explore the full profile